Literature DB >> 7520058

High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature.

P H Cottu1, S Giacchetti, L Mignot, B Epardeau, B Visot, J M Extra, M Espie, M Marty.   

Abstract

Medulloblastoma is a rare tumor in adult. High doses of megavoltage irradiation of the posterior fossa have been resulted in a better survival (48 to 78% at 5 years) of the patient. It is sensitive to a wide variety of chemotherapy drugs, but adjuvant chemotherapy has not been proved effective in adults although data are limited. We report the case of a cerebellar medulloblastoma with bony and medullar metastases. High-dose chemotherapy with peripheral stem-cell transplantation was performed while the patient was in remission following conventional chemotherapy. Complete remission lasted for 8 months. This therapeutic approach of metastatic medulloblastoma might be of value as this tumor is chemosensitive and not cured by conventional treatment. Internal radiotherapy by Samarium-153 was also carried out and proved to be an effective palliative treatment of pain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520058     DOI: 10.1007/bf01324599

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  Cerebellar medulloblastoma with skeletal metastases: case report and review of the literature.

Authors:  K R Booher; T M Schmidtknecht
Journal:  J Bone Joint Surg Am       Date:  1977-07       Impact factor: 5.284

3.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

4.  Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.

Authors:  G L Phillips; S N Wolff; J W Fay; R H Herzig; H M Lazarus; C Schold; G P Herzig
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

5.  Generalized osteoblastic bony metastases from medulloblastoma.

Authors:  E P Ho; A Lieber; F H DeLand; Y Maruyama
Journal:  Oncology       Date:  1976       Impact factor: 2.935

6.  Survival results in adult patients treated for medulloblastoma.

Authors:  M B Hazuka; D A DeBiose; R H Henderson; J J Kinzie
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

7.  Cerebellar medulloblastoma in adults.

Authors:  P G Hughes
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

8.  The change in patterns of relapse in medulloblastoma.

Authors:  N J Tarbell; J S Loeffler; B Silver; E Lynch; B L Lavally; W J Kupsky; R M Scott; S E Sallan
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

9.  Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981.

Authors:  H J Bloom; E M Bessell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

10.  Metastasizing neuroectodermal tumour.

Authors:  I Morild; S Mørk; H Nyland
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

View more
  3 in total

1.  Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.

Authors:  E Leo; P G Schlegel; A Lindemann
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

Review 2.  High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma.

Authors:  I J Dunkel; J L Finlay
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 3.  Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.

Authors:  Xanthoula Kostaras; Jacob C Easaw
Journal:  J Neurooncol       Date:  2013-07-23       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.